Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
DR Ferry, A Smith, J Malkhandi, DW Fyfe… - … cancer research: an …, 1996 - aacrjournals.org
We have performed a Phase I clinical trial with the naturally occurring flavonoid quercetin (3,3',4',5,7-pentahydroxyflavone).
Quercetin has antiproliferative activity in vitro and is known to …
Quercetin has antiproliferative activity in vitro and is known to …
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
…, FY Coxon, J Wadsley, W Mansoor, D Fyfe… - The lancet …, 2014 - thelancet.com
Background Second-line chemotherapy for patients with oesophagogastric adenocarcinoma
refractory to platinum and fluoropyrimidines has not shown benefits in health-related quality …
refractory to platinum and fluoropyrimidines has not shown benefits in health-related quality …
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
…, A Chatterjee, S Falk, A Garcia-Alonso, DW Fyfe… - The lancet …, 2014 - thelancet.com
Background Evidence is scarce for the effectiveness of therapies for oesophageal cancer
progressing after chemotherapy, and no randomised trials have been reported. We aimed to …
progressing after chemotherapy, and no randomised trials have been reported. We aimed to …
Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced …
…, T Roques, N Reed, C Candish, D Fyfe… - JAMA …, 2021 - jamanetwork.com
Importance Older and/or frail patients are underrepresented in landmark cancer trials. Tailored
research is needed to address this evidence gap. Objective The GO2 randomized clinical …
research is needed to address this evidence gap. Objective The GO2 randomized clinical …
High-beta turbulence in two-dimensional magnetohydrodynamics
D Fyfe, D Montgomery - Journal of Plasma Physics, 1976 - cambridge.org
Incompressible turbulent flows are investigated in the framework of ideal magnetohydrodynamics.
All the field quantities vary with only two spatial dimensions. Equilibrium canonical …
All the field quantities vary with only two spatial dimensions. Equilibrium canonical …
Dissipative, forced turbulence in two-dimensional magnetohydrodynamics
D Fyfe, D Montgomery, G Joyce - Journal of Plasma Physics, 1977 - cambridge.org
The equations of motion for turbulent two-dimensional magnetohydrodynamic flows are
solved in the presence of finite viscosity and resistivity, for the case in which external forces (…
solved in the presence of finite viscosity and resistivity, for the case in which external forces (…
Surface tension and viscosity with Lagrangian hydrodynamics on a triangular mesh
DE Fyfe, ES Oran, MJ Fritts - Journal of Computational Physics, 1988 - Elsevier
Numerical algorithms for surface tension and viscosity are presented in the context of a
Lagrangian treatment of incompressible hydrodynamics with a dynamically restructuring grid. …
Lagrangian treatment of incompressible hydrodynamics with a dynamically restructuring grid. …
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer
…, SJ Falk, S Elyan, A Garcia-Alonso, DW Fyfe… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The Cancer Esophagus Gefitinib trial demonstrated improved progression-free
survival with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib …
survival with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib …
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.
CV Christodoulou, DR Ferry, DW Fyfe… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To determine the maximum-tolerated dose (MTD) and the dose-limiting toxicities
(DLTs) of a weekly schedule of titanocene dichloride (TD) and to define the …
(DLTs) of a weekly schedule of titanocene dichloride (TD) and to define the …
Shock ignition target design for inertial fusion energy
…, JW Bates, SP Obenschain, ST Zalesak, DE Fyfe - Physics of …, 2010 - pubs.aip.org
Continuing work in the design of shock ignition targets is described. Because of reduced
implosion velocity requirements, low target adiabats, and efficient drive by short wavelength …
implosion velocity requirements, low target adiabats, and efficient drive by short wavelength …